Clinical Trials Browser

Phase 2 × INDUSTRY × Platinum-resistant Recurrent Ovarian Cancer × Clear all

NCT06434610 2025-01-27

A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Phase 2 Recruiting

Platinum-resistant Recurrent Ovarian Cancer

NCT05325229 2022-10-13

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer

Phase 2 Unknown

Platinum-resistant Recurrent Ovarian Cancer